Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Larimar Therapeutics Inc. buy Global_Player

Larimar Therapeutics Inc.
Start price
€2.18
24.03.25 / 50%
Target price
-
24.03.26
Performance (%)
-9.63%
End price
€1.97
29.03.25
Summary
This prediction ended on 29.03.25 with a price of €1.97. With a performance of -9.63%, the BUY prediction by Global_Player finished with a loss. Global_Player has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Larimar Therapeutics Inc. 6.897% 6.897% -1.064%
iShares Core DAX® 0,44 % 5,90 % 8,05 %
iShares Nasdaq 100 1,06 % 0,92 % 28,47 %
iShares Nikkei 225® 1,77 % 1,23 % 47,57 %
iShares S&P 500 0,37 % 1,92 % 23,20 %

According to Global_Player what are the pros and cons of Larimar Therapeutics Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by Global_Player for this prediction

In the thread Zafgen Inc. diskutieren

Buy Larimar Therapeutics Inc.

Global_Player 
0
Report Share
24.03.25 Buy -9.63%
In the thread Trading Zafgen Inc.
Prediction Buy
Perf. (%) -9.63%
Target price
Change
Ends at 24.03.26

Buy beendet

Global_Player 
0
Report Share
29.03.25

Stopped prediction by Global_Player for Larimar Therapeutics Inc.

buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.50
28.09.25
-
28.09.26
-20.89%
01.10.25

Could be worthwhile Investment >10% per year
Global_Player 
28.09.25 50%